Swasthya Adhikar Manch
Swasthya Adhikar Manch is a nonprofit organization in India which advocates for safety in clinical trials.
A women's branch advocated for health safety.[1]
Amulya Nidhi has said that pharma companies wish to avoid all regulation of their research, and because of this, people have to advocate for themselves.[2]
The organization filed a public interest litigation in 2012 asking for government intervention.[3] That petition became Swasthya Adhikar Manch v. Union of India, a court case. The Supreme Court of India sided with the organization in 2013 on a case about clinical trial safety.[4] In response, the government halted approval of new clinical trials until regulation was in place.[5]
The organization has made some progress in improving safety of clinical trials.[6]
In 2020 the organization commented that despite advances, transparency of health research information for the research participant is still not a common practice.[7]
References
[edit]- ^ Balestra, Giulietta Luul; Dasgupta, Jashodhara; Sandhya, Yatirajula Kanaka; Mannell, Jenevieve (2 December 2018). "Developing political capabilities with Community-Based Monitoring for health accountability: The case of the Mahila Swasthya Adhikar Manch". Global Public Health. 13 (12): 1853–1864. doi:10.1080/17441692.2018.1464586. PMID 29671373. S2CID 5001036.
- ^ GOI Monitor Desk (3 January 2015). "Pharma companies don't want any regulation". Goi Monitor.
- ^ Shelar, Jyoti (2 June 2018). "After a lull of five years, clinical trials on the rise in India". The Hindu.
- ^ Kay, M. (3 July 2014). "Indian Supreme Court demands clarity on clinical trial approvals". BMJ. 349 (jul03 13): g4383. doi:10.1136/bmj.g4383. PMID 24994706. S2CID 37807701.
- ^ Bagcchi, S. (4 October 2013). "Indian Supreme Court halts approval of new clinical trials until regulatory framework is set up". BMJ. 347 (oct04 2): f5996. doi:10.1136/bmj.f5996. PMID 24097130. S2CID 43077030.
- ^ Srinivasan, Sandhya (17 April 2016). "Trials and tribulations". Himal Southasian.
- ^ Datta, PT Jyothi (17 January 2020). "It has been a defining decade for clinical trials". Business Line.
External links
[edit]- Archived 7 May 2015 at the Wayback Machine